Business1% match
Federal Regulators Issue New Warning Over Rare Vision-Loss Risk Linked to Glp-1 Medications
The Food and Drug Administration Has Announced a New Warning Regarding a Potential Permanent Vision-Loss Risk Associated with Glp-1 Drugs Following a Scientific Investigation.
Nov 10, 2026